Conference abstractPublished 1 Sep 2015
Cell cycle and the world of biomarkers: What can we learn from proteomic studies?
Virginia Tech, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
High-throughput technologies such as LC-MS/MS generate large data-sets that flood scientists with unprecedented amounts of information. The conversion of such data into knowledge has the potential to not just answer long-sought biological questions, but to also revolutionize our approach to solve complex problems that lie at the root of human disease. The goal of our research is to study the molecular mechanisms of breast cancer cell-cycle to uncover aspects that lead to uncontrolled cell proliferation and the discovery of biomarkers and drug targets. Our model system consists of ER+ (MCF7), Her2+ (SKBR3) and non-tumorigenic (MCF10A) cells. Proteomic profiling of different stages of the cell cycle resulted in the identification of ~7000 proteins, with over half of the phosphorylated proteins being involved in proliferative or apoptotic signaling processes. The data revealed protein clusters involved in various signaling pathways, providing a preliminary vista of the cause-effect relationships that confer cancer cells a proliferative advantage. In particular, the G1 stage of the cell cycle included cell cycle inhibitory and DNA damage response proteins, and, most importantly, originators of proliferation and possible drivers through the G1/S transition point. Among the differentially expressed proteins, a rich network of ~200 proteins emerged with biomarker or drug-target potential. The impact of point mutations, insertions and deletions on the functional relevance of such proteins was explored. The findings expose the inherent complexity of the biological processes that unfold within the environment of a cell, and open bold, new opportunities for addressing the problem of diseased cell states.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectBiochemistry & Biotechnology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Iulia M Lazar”